Longitudinal changes in CD4+ T-cell memory responses induced by BCG vaccination of newborns

Journal of Infectious Diseases

Volumn 207, Issue 7, 2013, Pages 1084-1094

  Soares, Andreia P ^a   Kwong Chung, Cheong K C ^a   Choice, Terry ^a   Hughes, E Jane ^a   Jacobs, Gail ^a   Van Rensburg, Esme Janse ^a   Khomba, Gloria ^a   De Kock, Marwou ^a   Lerumo, Lesedi ^a   Makhethe, Lebohang ^a   Maneli, Mbulelo H ^a   Pienaar, Bernadette ^a   Smit, Erica ^a   Tena Coki, Nontobeko G ^a   Van Wyk, Leandre ^a   Boom, W Henry ^b   Kaplan, Gilla ^c   Scriba, Thomas J ^a   Hanekom, Willem A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Bacille Calmette Gu rin; Memory T cells; Newborns; T cell kinetics; Vaccination

Indexed keywords

BCG VACCINE; CD38 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 2; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; NEWBORN; NEWBORN CARE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VACCINATION;

BCG VACCINE; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; INFANT, NEWBORN; INTERFERON-GAMMA; INTERLEUKIN-2; LONGITUDINAL STUDIES; LYMPHOCYTE ACTIVATION; MALE; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

EID: 84874710922     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis941     Document Type: Article

References (49)

1. Global tuberculosis control. Geneva: WHO, 2011.
2. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a metaanalysis and assessment of cost-effectiveness. Lancet 2006; 367: 1173-80.
3. Abu-Raddad LJ, Sabatelli L, Achterberg JT, et al. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A 2009; 106:13980-5.
4. STOP tuberculosis Partnership. Tuberculosis vaccine candidates. http://www.stoptb.org/wg/new-vaccines/documents.asp. 2010.
5. Hatherill M. Prospects for elimination of childhood tuberculosis: the role of new vaccines. Arch Dis Child 2011; 96:851-6.
6. Wherry EJ, Barber DL, Kaech SM, Blattman JN, Ahmed R. Antigenindependent memory CD8 T cells do not develop during chronic viral infection. Proc Natl Acad Sci U S A 2004; 101:16004-9. (Pubitemid 39507917)
7. Wherry EJ, Teichgraber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003; 4:225-34. (Pubitemid 36322131)
8. Jelley-Gibbs DM, Brown DM, Dibble JP, Haynes L, Eaton SM, Swain SL. Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. J Exp Med 2005; 202:697-706. (Pubitemid 41248420)
9. Jelley-Gibbs DM, Dibble JP, Filipson S, Haynes L, Kemp RA, Swain SL. Repeated stimulation of CD4 effector T cells can limit their protective function. J Exp Med 2005; 201:1101-12. (Pubitemid 40524678)
10. McKinstry KK, Strutt TM, Swain SL. Regulation of CD4+ T-cell contraction during pathogen challenge. Immunol Rev 2010; 236:110-24.
11. Kagina BM, Abel B, Bowmaker M, et al. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine 2009; 27:5488-95.
12. Soares AP, Scriba TJ, Joseph S, et al. Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol 2008; 180:3569-77.
13. Tena-Coki NG, Scriba TJ, Peteni N, et al. CD4 and CD8 T-cell responses to mycobacterial antigens in African children. Am J Respir Crit Care Med 2010; 182:120-9.
14. Henao-Tamayo MI, Ordway DJ, et al. Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis. Clin Vaccine Immunol 2010; 17: 618-25.
15. Orme IM. The Achilles heel of BCG. Tuberculosis (Edinb) 2010; 90:329-32.
16. Lalor MK, Ben-Smith A, Gorak-Stolinska P, et al. Population differences in immune responses to Bacille Calmette-Guerin vaccination in infancy. J Infect Dis 2009; 199:795-800.
17. McShane H, Pathan AA, Sander CR, et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 2004; 10:1240-4. (Pubitemid 39540442)
18. Weir RE, Gorak-Stolinska P, Floyd S, et al. Persistence of the immune response induced by BCG vaccination. BMC Infect Dis 2008; 8:9.
19. Aronson NE, Santosham M, Comstock GW, et al. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA 2004; 291:2086-91. (Pubitemid 38580151)
20. Hanekom WA, Hughes J, Mavinkurve M, et al. Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods 2004; 291:185-95. (Pubitemid 39164348)
21. Govender L, Abel B, Hughes EJ, et al. Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease. Vaccine 2010; 29:51-7.
22. South African Expanded Programme on National Department of Health Immunisation. April 2009. http://www.doh.gov.za/docs/publicity/2009/ childimmunisation.pdf.
23. Shearer WT, Rosenblatt HM, Gelman RS, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003; 112:973-80. (Pubitemid 37412068)
24. Bastian M, Braun T, Bruns H, Rollinghoff M, Stenger S. Mycobacterial lipopeptides elicit CD4+ CTLs in Mycobacterium tuberculosis-infected humans. J Immunol 2008; 180:3436-46.
25. Appay V, Zaunders JJ, Papagno L, et al. Characterization of CD4(+) CTLs ex vivo. J Immunol 2002; 168:5954-8.
26. Soares A, Govender L, Hughes J, et al. Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J Immunol Methods 2010; 362:43-50.
27. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4:1191-8. (Pubitemid 37540688)
28. Cellerai C, Harari A, Vallelian F, Boyman O, Pantaleo G. Functional and phenotypic characterization of tetanus toxoid-specific human CD4(+) T cells following re-immunization. Eur J Immunol 2007; 37:1129-38. (Pubitemid 46925348)
29. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nat Immunol 1999; 14:659-60.
30. Miller JD, van der Most RG, Akondy RS, et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 2008; 28:710-22.
31. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Ann Rev Immunol 2004; 22:745-63. (Pubitemid 38680440)
32. Dooms H, Wolslegel K, Lin P, Abbas AK. Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7R alphaexpressing cells. J Exp Med 2007; 204:547-57. (Pubitemid 46457078)
33. McKinstry KK, Golech S, Lee WH, Huston G, Weng NP, Swain SL. Rapid default transition of CD4 T cell effectors to functional memory cells. J Exp Med 2007; 204:2199-211. (Pubitemid 47360879)
34. Li J, Huston G, Swain SL. IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 2003; 198:1807-15. (Pubitemid 38032114)
35. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995; 16:569-74.
36. Zhang X, Brunner T, Carter L, et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 1997; 185:1837-49. (Pubitemid 27242205)
37. Williams MA, Ravkov EV, Bevan MJ. Rapid culling of the CD4+ T cell repertoire in the transition from effector to memory. Immunity 2008; 28:533-45.
38. Scriba TJ, Tameris M, Mansoor N, et al. Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. J Infect Dis 2011; 203:1832-43.
39. Ota MO, Odutola AA, Owiafe PK, et al. Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants. Sci Transl Med 2011; 3:88ra56.
40. Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995; 96:29-35.
41. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346:1339-45.
42. Harari A, Vallelian F, Meylan PR, Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol 2005; 174:1037-45. (Pubitemid 40094300)
43. Harari A, Vallelian F, Pantaleo G. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur J Immunol 2004; 34:3525-33. (Pubitemid 40012170)
44. Appay V, Dunbar PR, Callan M, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-85. (Pubitemid 34407033)
45. Iezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 1998; 8:89-95. (Pubitemid 28097826)
46. Golden-Mason L, Burton JR Jr, Castelblanco N, et al. Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 2006; 44:1098-109. (Pubitemid 44748361)
47. Wherry EJ, Ha SJ, Kaech SM, et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007; 27:670-84. (Pubitemid 47615511)
48. Kagina BM, Abel B, Scriba TJ, et al. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns. Am J Respir Crit Care Med 2010; 182:1073-9.
49. Dudani R, Chapdelaine Y, Faassen Hv H, et al. Multiple mechanisms compensate to enhance tumor-protective CD8(+) T cell response in the long-term despite poor CD8(+) T cell priming initially: comparison between an acute versus a chronic intracellular bacterium expressing a model antigen. J Immunol 2002; 168:5737-45. (Pubitemid 34556158)